# Metabolic Effects of Melatonin Treatment

> **NCT03859934** · PHASE1 · COMPLETED · sponsor: **University of Aarhus** · enrollment: 17 (actual)

## Conditions studied

- Metabolic Disease
- Insulin Sensitivity
- Glucose Metabolism Disorders (Including Diabetes Mellitus)
- Type 2 Diabetes Mellitus
- Blood Pressure
- Inflammation

## Interventions

- **DRUG:** Melatonin
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03859934
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-26
- **Primary completion:** 2021-05-03
- **Final completion:** 2021-08-18
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2021-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03859934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03859934, "Metabolic Effects of Melatonin Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03859934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*